Greatbatch (GB) Stock Research, Analysis & News
Quick Analysis on Greatbatch (GB) Stock as of May 18, 2013
 | Previous Closing Price $31.01 is above 50 day moving average of $29.66 |
| Previous Closing Price $31.01 is above 200 day moving average of $26.28 |
| The Price/Earnings To Growth ratio (PEG) is great than 1 |
 | The Stock pays no dividend |
| The closing price $31.01 is less than -3.90% away from its one year target price of $29.80 |
| Good Price to Sale Ratio 1.17 |
| Good Price to Book Ratio of 1.51 |
 | Current Short Ratio 7.60 is great than 1 |
| Earning per Share $-0.153 is negative. Greatbatch is lossing money. |
(See more information about Greatbatch (GB) Stock below)
Greatbatch (GB) Stock Profile Summary
Greatbatch, Inc. provides technology solutions for medical and industrial applications. The company operates in two segments, Greatbatch Medical and Electrochem Solutions. The Greatbatch Medical segment designs and manufactures systems, components, and devices for the cardiac rhythm management, neuromodulation, vascular access, and orthopaedic markets. Its products include batteries, capacitors, filtered and unfiltered feedthroughs, engineered components, and enclosures used in implantable medical devices; instruments and delivery systems used in hip and knee replacement, and trauma and spine surgeries, as well as in hip, knee, and shoulder implants; and introducers, catheters, steerable sheaths, and implantable stimulation leads. This segment also offers value-added assembly and design engineering services for medical systems and devices. It serves primarily multi-national original equipment manufacturers. The Electrochem Solutions segment provides technology solutions for critical industrial applications to various companies involved in energy, security, portable medical, and environmental monitoring markets. Its products comprise cells, primary and rechargeable battery packs, and wireless sensors. This segment sells its products directly to end users; manufacturers, who incorporate these products into other devices for resale; and distributors. Greatbatch, Inc. sells its products primarily in the United States, Puerto Rico, the United Kingdom, Ireland, France, and Belgium. The company was founded in 1970 and is based in Clarence, New York.
Greatbatch (GB) Stock Key Statistics Research and Analysis as of May 18, 2013
| Stock Exchange | NYSE |
| Market Capitalization | $747.6M
|
| Trade Volume (Average Trading Volume) | 129,823 (125,254) |
| Price/Sales | 1.17 |
| Price/Book | 1.51 |
| Earning/Share | $-0.153 |
| Current Year EPS Estimate | $1.96 |
| Next Year EPS Estimate | $2.12 |
| Previous Closing Price | $31.01 |
| 50 Day Price Moving Average | $29.66 |
| 200 Day Price Moving Average | $26.28 |
| 1 yr Target Price | $29.80 |
| PEG Ratio | 1.32 |
| Short Ratio | 7.60 |
| EBITDA | $115.3M |
Greatbatch (GB) Stock Competitor Research and Analysis
Stock Research on Greatbatch (GB)
Latest Market News on Greatbatch (GB)
Click here to find the latest news on Greatbatch (GB)
Looking for Market Opportunties?
Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center
See other companies in the same industry
Medtronic, Inc. (MDT) Unitedhealth Group, Inc. (UNH) WellPoint Inc. (WLP) Aetna Inc. (AET)
Research on Greatbatch (GB)
